A recent publication describes similar results with broad ActRIIA/B receptor blockade during GLP-1 RA-induced weight loss in obese mice, i.e., prevention of muscle loss with increased fat loss, resulting in multiple metabolic benefits 45
For more comprehensive information about peptides and their roles in health, consider trusted resources like the Health Wikipedia entry
One of the first questions many people ask is: Who are GLP-1 medications for
Side-effect tracking that gets it Log nausea, fatigue, constipation and more on a severity scale
For context, the dual agonist tirzepatide is studied in SURMOUNT ( NEJM , 2022) and SURMOUNT-OSA ( NEJM , 2024)
Efpeglenatide and clinical outcomes with and without concomitant sodium-glucose cotransporter-2 inhibition use in type 2 diabetes: exploratory analysis of the AMPLITUDE-O trial